Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-31 5:10 pm Purchase |
2022-01-27 | 13D | Kodiak Sciences Inc. KOD |
Baker Bros. Advisors LP | 15,566,068 30.100% |
848,776 (+5.77%) |
Filing History |
| 2021-12-16 5:23 pm Unchanged |
2021-12-14 | 13D | Entrada Therapeutics, Inc. TRDA |
Baker Bros. Advisors LP | 4,704,419 15.100% |
0 (Unchanged) |
Filing History |
| 2021-11-10 4:50 pm Purchase |
2021-11-02 | 13G | Entrada Therapeutics, Inc. TRDA |
Baker Bros. Advisors LP | 4,704,419 15.100% |
4,704,419 (New Position) |
Filing History |
| 2021-10-01 5:10 pm Purchase |
2021-09-29 | 13D | Kodiak Sciences Inc. KOD |
Baker Bros. Advisors LP | 14,717,292 28.500% |
393,424 (+2.75%) |
Filing History |
| 2021-07-26 5:21 pm Purchase |
2021-07-22 | 13D | Kodiak Sciences Inc. KOD |
Baker Bros. Advisors LP | 14,323,868 27.800% |
269,170 (+1.92%) |
Filing History |
| 2021-07-22 4:20 pm Purchase |
2021-07-20 | 13D | TScan Therapeutics, Inc. TCRX |
Baker Bros. Advisors LP | 1,425,000 7.600% |
1,425,000 (New Position) |
Filing History |
| 2021-05-20 5:25 pm Unchanged |
2021-05-10 | 13D | Immunocore Holdings plc IMCR |
Baker Bros. Advisors LP | 3,352,357 7.700% |
0 (Unchanged) |
Filing History |
| 2021-05-18 4:42 pm Sale |
2021-05-14 | 13D | Incyte Corporation INCY |
Baker Bros. Advisors LP | 32,524,420 14.800% |
-57,539 (-0.18%) |
Filing History |
| 2021-05-18 4:41 pm Purchase |
2021-05-14 | 13D | Seagen Inc. SGEN |
Baker Bros. Advisors LP | 47,618,503 26.200% |
3,226 (+0.01%) |
Filing History |
| 2021-05-10 5:08 pm Purchase |
2021-04-30 | 13G | Verastem, Inc. VSTM |
Baker Bros. Advisors LP | 1,557,141 10.900% |
711,805 (+84.20%) |
Filing History |
| 2021-04-12 5:05 pm Purchase |
2021-03-31 | 13G | Otonomy, Inc. OTIC |
Baker Bros. Advisors LP | 7,220,074 14.900% |
7,220,074 (New Position) |
Filing History |
| 2021-04-09 5:14 pm Sale |
2021-03-31 | 13G | Idera Pharmaceuticals, Inc. IDRA |
Baker Bros. Advisors LP | 245,702 4.900% |
-300,335 (-55.00%) |
Filing History |
| 2021-04-02 4:01 pm Unchanged |
2021-03-26 | 13D | Talis Biomedical Corporation TLIS |
Baker Bros. Advisors LP | 2,495,947 67.500% |
0 (Unchanged) |
Filing History |
| 2021-03-19 4:07 pm Purchase |
2021-03-16 | 13D | Aeglea BioTherapeutics, Inc. AGLE |
Baker Bros. Advisors LP | 196,048 9.900% |
346 (+0.18%) |
Filing History |
| 2021-03-05 5:17 pm Unchanged |
2021-02-23 | 13D | Aeglea BioTherapeutics, Inc. AGLE |
Baker Bros. Advisors LP | 195,701 9.900% |
0 (Unchanged) |
Filing History |
| 2021-03-05 5:05 pm Unchanged |
2021-03-01 | 13D | Kodiak Sciences Inc. KOD |
Baker Bros. Advisors LP | 14,054,698 27.400% |
0 (Unchanged) |
Filing History |
| 2021-02-26 4:52 pm Purchase |
2021-02-17 | 13D | Talis Biomedical Corporation TLIS |
Baker Bros. Advisors LP | 2,495,947 67.600% |
2,495,947 (New Position) |
Filing History |
| 2021-02-16 5:09 pm Purchase |
2020-12-31 | 13G | Ascendis Pharma A/S ASND |
Baker Bros. Advisors LP | 3,540,270 6.600% |
150,000 (+4.42%) |
Filing History |
| 2021-02-16 5:09 pm Purchase |
2020-12-31 | 13G | Heron Therapeutics, Inc. HRTX |
Baker Bros. Advisors LP | 8,064,832 8.700% |
84,979 (+1.06%) |
Filing History |
| 2021-02-16 5:09 pm Purchase |
2020-12-31 | 13G | Invitae Corporation NVTAQ |
Baker Bros. Advisors LP | 15,774,095 8.900% |
6,552,017 (+71.05%) |
Filing History |